COMMUNIQUÉS West-GlobeNewswire

Medtronic EVP & CFO Karen L. Parkhill to Speak at Morgan Stanley Global Healthcare Conference
04/09/2018
DUBLIN - September 4, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Friday, September 14 [...]
OrthoPediatrics Corp. to Participate at the Morgan Stanley 16th Annual Global Healthcare Conference
04/09/2018
WARSAW, Ind., Sept. 04, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & [...]
Grown Rogue Builds a Multi-State Seed-to-Experience Cannabis Brand -- CFN Media
04/09/2018
SEATTLE, WA, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Abeona Announces Participation at Upcoming Conferences
04/09/2018
Citi's 13th Annual Biotech Conference - September 5-6 th in Boston, MA Jefferies Gene Therapy Summit - September 27 th in New York, NY NEW YORK and CLEVELAND, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc [...]
Sarepta Therapeutics to Present at Two Upcoming Investor Conferences
04/09/2018
CAMBRIDGE, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
Cannabis Leaf is Now Apotheca Biosciences (PCFP), Company's Products and R & D Focuses on Opioid Crisis, a National Public Health Emergency
04/09/2018
SAINT PETERSBURG, FL, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
Scythian Biosciences Corp. Announces Andy DeFrancesco as a New Director
04/09/2018
TORONTO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today that it has appointed Andrew DeFrancesco to [...]
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2019 After Market Close on September 10, 2018
04/09/2018
TUSTIN, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
NeoChord Announces Successful Completion of First Beating Heart Repair Procedures in China
04/09/2018
ST. LOUIS PARK, Minn., Sept. 04, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve [...]
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients
04/09/2018
MIAMI, Sept. 04, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) has initiated a Phase 2 clinical trial to study the safety and efficacy of RAYALDEE ® as a new treatment for secondary hyperparathyroidism (SHPT [...]
Zogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut Syndrome
04/09/2018
67% of Patients Achieved At Least a 50% Reduction in Convulsive Seizures Global Phase 3 Randomized, Controlled Study in LGS Currently Enrolling Patients EMERYVILLE, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, [...]
MediWound to Present at 13th Annual Wells Fargo Securities Healthcare Conference
04/09/2018
YAVNE, Israel, Sept. 04, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
AIT Therapeutics to Present Nitric Oxide Data at Two Upcoming Scientific Conferences
04/09/2018
Highlights at European Respiratory Society (ERS) to include updated data from company’s NO-BRO Pilot study of high-dose inhaled nitric oxide (NO) in infants hospitalized with acute bronchiolitis Additional pre-clinical [...]
Establishment Labs announces transition to a Direct Sales Force in the United Kingdom
04/09/2018
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics [...]
Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Low Lean Body Mass in Prader-Willi Syndrome
04/09/2018
REDWOOD CITY, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced [...]
Catalyst Biosciences Announces Publication of Marzeptacog Alfa (Activated) Phase 1 Data in The Journal of Thrombosis and Haemostasis
04/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Oryzon to present at upcoming international conferences
04/09/2018
Rodman & Renshaw 20th Annual Global Investment Conference, New York, USA 19th International Conference on Alzheimer’s Drug Discovery, Jersey City, NJ, USA BIO-SPAIN-2018, Sevilla, SPAIN European Molecular Biology [...]
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy
04/09/2018
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]
Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC to be Published in European Radiology
04/09/2018
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the result of [...]

Pages